Christopher Devine, MD
Ophthalmology · Cincinnati, OHNPI 1205838562
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,081 of the $2,396 with a category attached, or 86.8%. 12 manufacturers reported payments, led by Abiomed at 25.3% of the total.
Across 64 payments — averaging $37.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$605
- AbbVie$385
- Genentech USA, Inc.$306
- Novartis$282
- Alimera Sciences, Inc.$249
- Astellas Pharma US Inc$162
- plus $407 from 6 others
Across 112 payments — averaging $5544.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Roche TCRC, Inc.$295K
- AstraZeneca$99K
- Boehringer Ingelheim$70K
- Regeneron$67K
- Amgen$39K
- Boehringer Ingelheim International GmbH$32K
- plus $20K from 3 others
What the payments were for
- Travel & lodging$31513%
- Food & beverage$2,08187%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 7 | $605 |
| AbbVie(2 entities) | 14 | $385 |
| Genentech USA, Inc. | 13 | $306 |
| Novartis | 5 | $282 |
| Alimera Sciences, Inc. | 5 | $249 |
| Astellas Pharma US Inc | 6 | $162 |
| Regeneron Healthcare Solutions, Inc. | 5 | $123 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $99 |
| Biogen | 3 | $65 |
| Apellis Pharmaceuticals, Inc. | 2 | $44 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $43 |
| Bausch & Lomb Americas Inc. | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,396 in reported general payments places this provider in the 65th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 141 | $3,520 |
| Ofloxacin | 140 | $1,305 |
| Latanoprost | 25 | $387 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Cincinnati
- Robert OsherCincinnati$720K
- Christopher RiemannCincinnati$463K
- Anup KhatanaCincinnati$347K
- Michael SnyderCincinnati$216K
- Daniel MillerCincinnati$75K
- Robert SiskCincinnati$46K
- Michael NordlundCincinnati$40K
- Adam KaufmanCincinnati$19K
- Haroon ChaudhryCincinnati$18K
- Karen KlugoCincinnati$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.